Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 129
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Identification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
Role of oxidative stress in female reproduction
Agarwal, A., Gupta, S., & Sharma, R. K. (2005) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-3-28 · Cited by 1,729
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Thalidomide-induced Teratogenesis: History and Mechanisms
Vargesson, N. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21096 · Cited by 912
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management
Rajkumar, S. V. (2022) · American Journal of Hematology · doi:10.1002/ajh.26590 · Cited by 883
Hideshima, T., Chauhan, D., Shima, Y., Raje, N., Davies, F. E., Tai, Y.-T., Treon, S. P., Lin, B., Schlossman, R. L., Richardson, P., et al. (2000) · Blood · doi:10.1182/blood.v96.9.2943 · Cited by 875
The evolution of thalidomide and its IMiD derivatives as anticancer agents
Bartlett, J. B., Dredge, K., & Dalgleish, A. G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1323 · Cited by 809
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management
Rajkumar, S. V. (2020) · American Journal of Hematology · doi:10.1002/ajh.25791 · Cited by 789
CD40/CD154 Interactions at the Interface of Tolerance and Immunity
Quezada, S. A., Jarvinen, L. Z., Lind, E. F., & Noelle, R. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104533 · Cited by 683
Placental oxidative stress: from miscarriage to preeclampsia
Burton, G. J., & Jauniaux, E. (2004) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2004.03.003 · Cited by 673
Thalidomide: The Tragedy of Birth Defects and the Effective Treatment of Disease
Kim, J. H., & Scialli, A. R. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr088 · Cited by 659
Barlogie, B., Desikan, R., Eddlemon, P., Spencer, T., Zeldis, J., Munshi, N., Badros, A., Zangari, M., Anaissie, E., Epstein, J., et al. (2001) · Blood · doi:10.1182/blood.v98.2.492 · Cited by 541
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management
Rajkumar, S. V. (2024) · American Journal of Hematology · doi:10.1002/ajh.27422 · Cited by 534
Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma
Rajkumar, S. V., Hayman, S., Gertz, M. A., Dispenzieri, A., Lacy, M. Q., Greipp, P. R., Geyer, S., Iturria, N., Fonseca, R., Lust, J. A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.116 · Cited by 512
Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity
Keifer, J. A., Guttridge, D. C., Ashburner, B. P., & Jr.Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100938200 · Cited by 478
Angiogenesis Inhibitors: Current Strategies and Future Prospects
Cook, K. M., & Figg, W. D. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20075 · Cited by 474
Microtia: Epidemiology and genetics
Luquetti, D. V., Heike, C. L., Hing, A. V., Cunningham, M. L., & Cox, T. C. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34352 · Cited by 457
Multiple myeloma: 2016 update on diagnosis, risk‐stratification, and management
Rajkumar, S. V. (2016) · American Journal of Hematology · doi:10.1002/ajh.24402 · Cited by 456
Wells, P. G., McCallum, G. P., Chen, C. S., Henderson, J. T., Lee, C. J. J., Perstin, J., Preston, T. J., Wiley, M. J., & Wong, A. W. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfn263 · Cited by 430
“Thalidomide causes embryonic oxidative DNA damage in the rabbit, which is susceptible to birth defects similar to those observed in thalidomide-exposed humans, but does not increase DNA oxidation in mice, which are not susceptible to thalidomide teratogenicity (Parman et al., 1999).”
Self-citationRaza, A., Reeves, J. A., Feldman, E. J., Dewald, G. W., Bennett, J. M., Deeg, H. J., Dreisbach, L., Schiffer, C. A., Stone, R. M., Greenberg, P. L., et al. (2008) · Blood · doi:10.1182/blood-2007-01-068833 · Cited by 425
NADPH Oxidase-Dependent Signaling in Endothelial Cells: Role in Physiology and Pathophysiology
Frey, R. S., Ushio–Fukai, M., & Malik, A. B. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2220 · Cited by 420
Embryo stability and vulnerability in an always changing world
Hamdoun, A., & Epel, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610108104 · Cited by 388
Cancer drug discovery by repurposing: teaching new tricks to old dogs
Gupta, S. C., Sung, B., Prasad, S., Webb, L. J., & Aggarwal, B. B. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.06.005 · Cited by 340
SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate
Matyskiela, M. E., Couto, S., Zheng, X., Lu, G., Hui, J., Stamp, K., Drew, C., Ren, Y., Wang, M., Carpenter, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0129-x · Cited by 338
Eisen, T., Boshoff, C., Mak, I., Sapunar, F., Vaughan, M. M., Pyle, L., Johnston, S. R. D., Ahern, R., Smith, I. E., & Gore, M. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1004 · Cited by 338
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
Gupta, S., Agarwal, A., Banerjee, J., & Alvarez, J. G. (2007) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000261644.89300.df · Cited by 329
Zhu, Y. X., Kortuem, K. M., & Stewart, A. K. (2013) · Leukemia & Lymphoma · doi:10.3109/10428194.2012.728597 · Cited by 293
Ornoy, A. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.04.004 · Cited by 279
Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance
Zhou, S., Chan, E., Duan, W., Huang, M., & Chen, Y.-Z. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-200028812 · Cited by 274
Haendeler, J., Hoffmann, J., Brandes, R. P., Zeiher, A. M., & Dimmeler, S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4598-4610.2003 · Cited by 268
Mechanism of action in thalidomide teratogenesis
Stephens, T. D., Bunde, C. J. W., & Fillmore, B. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00388-3 · Cited by 259
Oxygen, early embryonic metabolism and free radical-mediated embryopathies
Burton, G. J., Hempstock, J., & Jauniaux, E. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62060-3 · Cited by 251
Health effects of uranium: new research findings
Brugge, D., & Buchner, V. (2011) · Reviews on Environmental Health · doi:10.1515/reveh.2011.032 · Cited by 248
Kupffer Cell Metabolism and Function.
Nguyen‐Lefebvre, A. T., & Horuzsko, A. (2015) · PubMed · Cited by 241
Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species
WELLS, P., BHULLER, Y., CHEN, C., JENG, W., KASAPINOVIC, S., KENNEDY, J., KIM, P., LAPOSA, R., MCCALLUM, G., & NICOL, C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2005.01.061 · Cited by 236
Self-citationRaje, N., & Anderson, K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199911183412110 · Cited by 230
Minimising the potential for metabolic activation in drug discovery
Kalgutkar, A. S., & Soglia, J. R. (2005) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.1.1.91 · Cited by 229
Floyd, R. A., Kopke, R. D., Choi, C.-H., Foster, S. B., Doblas, S., & Towner, R. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.017 · Cited by 228
Thalidomide as initial therapy for early-stage myeloma
Rajkumar, S. V., Gertz, M. A., Lacy, M. Q., Dispenzieri, A., Fonseca, R., Geyer, S. M., Iturria, N., Kumar, S., Lust, J. A., Kyle, R. A., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402866 · Cited by 225
Das, U. N. (2002) · PubMed · Cited by 224
T‐cell costimulatory pathways in allograft rejection and tolerance
Rothstein, D. M., & Sayegh, M. H. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00088.x · Cited by 222
Zhu, Y. X., Braggio, E., Shi, C.-X., Kortuem, K. M., Bruins, L. A., Schmidt, J. E., Chang, X.-B., Langlais, P., Luo, M., Jedlowski, P., et al. (2014) · Blood · doi:10.1182/blood-2014-02-557819 · Cited by 213
Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management
Rajkumar, S. V. (2018) · American Journal of Hematology · doi:10.1002/ajh.25117 · Cited by 209
Novel therapies targeting the myeloma cell and its bone marrow microenvironment
HIDESHIMA, T. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90033-8 · Cited by 201
Kawai, T., Sogawa, H., Boskovic, S., Abrahamian, G., Smith, R.-N., Wee, S.-L., Andrews, D., Nadazdin, O., Koyama, I., Sykes, M., et al. (2004) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00523.x · Cited by 200
The roles of glutathione peroxidases during embryo development
Ufer, C. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00012 · Cited by 195
The role of ultrasound imaging in diagnosing and investigating early pregnancy failure
Jauniaux, E., Johns, J., & Burton, G. J. (2005) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.1892 · Cited by 189
The role of oxidative stress in fetal alcohol spectrum disorders
Brocardo, P. S., Gil-Mohapel, J., & Christie, B. R. (2011) · Brain Research Reviews · doi:10.1016/j.brainresrev.2011.02.001 · Cited by 185
Takahashi, M., Keicho, K., Takahashi, H., Ogawa, H., Schulte, R. M., & Okano, A. (2000) · Theriogenology · doi:10.1016/s0093-691x(00)00332-0 · Cited by 184
Teratogenic effects of thalidomide: molecular mechanisms
Ito, T., Ando, H., & Handa, H. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0619-9 · Cited by 182
NICOL, C. J., ZIELENSKI, J., TSUI, L., & WELLS, P. G. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.111 · Cited by 180
Self-citationChang, T. I., Horal, M., Jain, S. K., Wang, F., Patel, R., & Loeken, M. R. (2003) · Diabetologia · doi:10.1007/s00125-003-1063-2 · Cited by 175
The Biochemistry of Drug Metabolism – An Introduction: Part 2. Redox Reactions and Their Enzymes
Testa, B., & Krämer, S. D. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790032 · Cited by 171
Thalidomide metabolism by the CYP2C subfamily.
Ando, Y., Fuse, E., & Figg, W. D. (2002) · PubMed · Cited by 171
Rohwedel, J., Guan, K., Hegert, C., & Wobus, A. M. (2001) · Toxicology in Vitro · doi:10.1016/s0887-2333(01)00074-1 · Cited by 168
Oxidative stress as a mechanism of teratogenesis
Hansen, J. M. (2006) · Birth Defects Research Part C: Embryo Today: Reviews · doi:10.1002/bdrc.20085 · Cited by 164
Majumdar, S., Lamothe, B., & Aggarwal, B. B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2644 · Cited by 160
Yamamoto, J., Ito, T., Yamaguchi, Y., & Handa, H. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00116k · Cited by 158
Congenital Malformations in Offspring of Diabetic Mothers—Animal and Human Studies
Eriksson, U. J., Cederberg, J., & Wentzel, P. (2003) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1021879504372 · Cited by 158
Selenium, Selenoproteins, and Female Reproduction: A Review
Qazi, I. H., Angel, C., Yang, H., Pan, B., Zoidis, E., Zeng, C., Han, H., & Zhou, G. (2018) · Molecules · doi:10.3390/molecules23123053 · Cited by 157
Aerbajinai, W., Zhu, J., Gao, Z., Chin, K., & Rodgers, G. P. (2007) · Blood · doi:10.1182/blood-2007-01-065201 · Cited by 156
Nieden, N. Z. Z., Kempka, G., & Ahr, H. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2003.09.019 · Cited by 140
Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit
Clark, R. L., White, T. E. K., Clode, S. A., GAUNT, I. F., Winstanley, P., & Ward, S. A. (2004) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20027 · Cited by 150
Teratology in the 20th century
Kalter, H. (2003) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(03)00010-2 · Cited by 148
Hsieh, T., Liu, T., Chia, Y., Chern, C., Lu, F., Chuang, M.-C., Mau, S.-Y., Chen, S.-H., Syu, Y.-H., & Chen, C. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.01.008 · Cited by 146
Atamna, H., Paler-Martínez, A., & Ames, B. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6741 · Cited by 144
Structural basis of thalidomide enantiomer binding to cereblon
Mori, T., Ito, T., Liu, S., Ando, H., Sakamoto, S., Yamaguchi, Y., Tokunaga, E., Shibata, N., Handa, H., & Hakoshima, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-19202-7 · Cited by 143
Glutamic Acid and Its Derivatives: Candidates for Rational Design of Anticancer Drugs
Ali, I., Wani, W. A., Haque, A., & Saleem, K. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.62 · Cited by 142
Schütt, P., Brandhorst, D., Stellberg, W., Poser, M., Ebeling, P. R., Müller, S., Buttkereit, U., Opalka, B., Lindemann, M., Grosse‐Wilde, H., et al. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190500472503 · Cited by 138
Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
Safinia, N., Scottà, C., Vaikunthanathan, T., Lechler, R. I., & Lombardi, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00438 · Cited by 136
Lupo, P. J., Symanski, E., Waller, D. K., Chan, W., Langlois, P. H., Canfield, M. A., & Mitchell, L. E. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002212 · Cited by 135
p63 is a cereblon substrate involved in thalidomide teratogenicity
Asatsuma-Okumura, T., Ando, H., De Simone, M., Yamamoto, J., Sato, T., Shimizu, N., Asakawa, K., Yamaguchi, Y., Ito, T., Guerrini, L., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0366-7 · Cited by 134
Glutathione during embryonic development
Hansen, J. M., & Harris, C. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2014.12.001 · Cited by 134
Thalidomide induces limb deformities by perturbing the Bmp/Dkkl/Wnt signaling pathway
Knobloch, J., Shaughnessy, J. D., & Rüther, U. (2007) · The FASEB Journal · doi:10.1096/fj.06-7603com · Cited by 134
Fluid compartments of the embryonic environment
Jauniaux, E. R. M., & Gulbis, B. (2000) · Human Reproduction Update · doi:10.1093/humupd/6.3.268 · Cited by 134
Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop
Barrett, C., & Richens, A. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00237-1 · Cited by 132
Redox Control in Mammalian Embryo Development
Ufer, C., Wang, C. C., Borchert, A., Heydeck, D., & Kühn, H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3044 · Cited by 131
Oxidative DNA Damage: Endogenous and Chemically Induced
Williams, G. M., & Jeffrey, A. M. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1433 · Cited by 129
Maternal Arsenic Exposure Associated With Low Birth Weight in Bangladesh
Huyck, K. L., Kile, M. L., Mahiuddin, G., Quamruzzaman, Q., Rahman, M., Breton, C. V., Dobson, C., Frelich, J., Hoffman, E. B., Yousuf, J., et al. (2007) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181566ba0 · Cited by 128
Embryo Toxicity and Teratogenicity of Formaldehyde
Thrasher, J. D., & Kilburn, K. H. (2001) · Archives of Environmental Health An International Journal · doi:10.1080/00039890109604460 · Cited by 128
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma
Rajkumar, S. V., & Witzig, T. E. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.2000.0188 · Cited by 127
Nucleoredoxin, a Novel Thioredoxin Family Member Involved in Cell Growth and Differentiation
Funato, Y., & Miki, H. (2007) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1550 · Cited by 125
Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits
Wells, P. G., McCallum, G. P., Lam, K. C. H., Henderson, J. T., & Ondovcik, S. L. (2010) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.20177 · Cited by 124
Self-citationJauniaux, E. R. M., Cindrová‐Davies, T., Johns, J., Dunster, C., Hempstock, J., Kelly, F. J., & Burton, G. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031332 · Cited by 123
Phase II Evaluation of Thalidomide in Patients With Metastatic Breast Cancer
Baidas, S. M., Winer, E. P., Fleming, G. F., Harris, L. N., Pluda, J. M., Crawford, J. G., Yamauchi, H., Isaacs, C. J., Hanfelt, J., Tefft, M. C., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2710 · Cited by 122
Meermeier, E. W., Welsh, S. J., Sharik, M. E., Du, M. T., Garbitt, V. M., Riggs, D. L., Shi, C., Stein, C. K., Bergsagel, M., Chau, B. H., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0038 · Cited by 120
Vitamin E as an Antioxidant in Female Reproductive Health
Mutalip, S. S. M., Rahim, S. A., & Rajikin, M. H. (2018) · Antioxidants · doi:10.3390/antiox7020022 · Cited by 118
Advances in Understanding the Molecular Causes of Diabetes-Induced Birth Defects
Loeken, M. R. (2005) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2005.09.007 · Cited by 115
Thalidomide Inhibits Angiogenesis in Embryoid Bodies by the Generation of Hydroxyl Radicals
Sauer, H., Günther, J., Hescheler, J., & Wartenberg, M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64714-1 · Cited by 115
Shedding light on an old mystery: Thalidomide suppresses survival pathways to induce limb defects
Knobloch, J., & Rüther, U. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5793 · Cited by 114
The clinical significance of cereblon expression in multiple myeloma
Schuster, S. R., Kortuem, K. M., Zhu, Y. X., Braggio, E., Shi, C.-X., Bruins, L. A., Schmidt, J. E., Ahmann, G., Kumar, S., Rajkumar, S. V., et al. (2014) · Leukemia Research · doi:10.1016/j.leukres.2013.08.015 · Cited by 113
Morphogenesis and dysmorphogenesis of the appendicular skeleton
Shum, L., Coleman, C. M., Hatakeyama, Y., & Tuan, R. S. (2003) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.10012 · Cited by 113
Thalidomide-analogue biology: immunological, molecular and epigenetic targets in cancer therapy
Shortt, J., Hsu, A. K., & Johnstone, R. W. (2013) · Oncogene · doi:10.1038/onc.2012.599 · Cited by 112
Hansen, J. M., & Harris, C. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604771978291 · Cited by 112
The balance of deletion and regulation in allograft tolerance
Zheng, X. X., Fueyo, A. S., Domenig, C. M., & Strom, T. B. (2003) · Immunological Reviews · doi:10.1046/j.1600-065x.2003.00089.x · Cited by 111
Mahler, H. I. M., Kulik, J. A., Harrell, J., Correa, A., Gibbons, F. X., & Gerrard, M. (2005) · Archives of Dermatology · doi:10.1001/archpedi.161.4.356 · Cited by 110
Sekeres, M. A., Maciejewski, J. P., Giagounidis, A. A. N., Wride, K., Knight, R., Raza, A., & List, A. F. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5770 · Cited by 110
Haendeler, J., Tischler, V., Hoffmann, J., Zeiher, A. M., & Dimmeler, S. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.041 · Cited by 110
Use of Rapamycin in the Induction of Tolerogenic Dendritic Cells
Fischer, R. T., Turnquist, H. R., Taner, T., & Thomson, A. W. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-71029-5_10 · Cited by 109
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.